Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

A preliminary preclinical assessment of macromolecular crowding in tissue engineering

Spanoudes K., Cubillo LT., Korntner SH., Gaspar D., Zeugolis DI.

Animal Study on Chronic Wound, Scar, published in Sci Prog (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Prog (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41564240
PMCID
PMC12830566
DOI
10.1177/00368504251406914

Abstract (original English)

ObjectivesAlthough bone marrow mesenchymal stromal cells (BMSCs) are extensively used in biomedicine, they have yet to be used in the commercial development of a tissue engineered medicine. It has been argued that the major roadblock in their commercial deployment is the lengthy in vitro culture periods required for the development of implantable tissue surrogates. Macromolecular crowding (MMC) has been shown to enhance and increase extracellular matrix deposition in eukaryotic cell culture, allowing for the accelerated development of tissue facsimiles.MethodsWith these in mind, human BMSCs were cultured under MMC conditions and the developed tissue-engineered medicine was assessed in vitro and in vivo in a humanised athymic nude mouse excisional wound splinting model.ResultsStarting with basic cell function analysis, MMC did not significantly affect cell metabolic activity, viability and proliferation. Electrophoresis and immunofluorescence analyses revealed that MMC significantly increased collagen type I and collagen type IV deposition, without significantly affecting collagen type III deposition. Flow cytometry analysis demonstrated similar CD44, CD73, CD90, CD146, HLA-ABC, CD31, CD45, CD80 and CD86 expression between the without and the with MMC groups. Interestingly though the MMC group had higher CD105 and lower HLA-DR expression than the without MMC group. Preclinical a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cells, CulturedExtracellular MatrixMesenchymal Stem CellsAnimalsHumansMiceMice, NudeTissue EngineeringWound HealingCell Proliferation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research